Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

YR2 LCRS Pharm > Inflammatory Bowel Disease > Flashcards

Inflammatory Bowel Disease Flashcards

1
Q

What are the two main diseases that come under Inflammatory Bowel Disease?

A

Ulcerative Colitis

Crohn’s Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the underlying pathogenesis of IBD based on?

A

A defective interaction between the mucosal immune system + gut flora

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List 4 key environmental risk factors associated with IBD

A

Diet
Smoking
Medication
Microbiome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which T cell responses are involved in:

a. Ulcerative Colitis
b. Crohn’s Disease

A

UC: Th2
CD: Th1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the main cytokines in:

a. Ulcerative Colitis
b. Crohn’s Disease

A

UC: IL-13
CD: TNF-alpha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which layers of the gut are affected in:

a. Ulcerative Colitis
b. Crohn’s Disease

A

UC: Mucosa + Submucosa
CD: All Layers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe which regions of the gut are affected in:

a. Ulcerative Colitis
b. Crohn’s Disease

A

UC: Starts at the rectum + spreads proximally (continuous inflammation)
CD: Any part of GI tract (mouth to anus). Patchy inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Are abscesses, fissures and fistulae common in:

a. Ulcerative Colitis
b. Crohn’s Disease

A

UC: No
CD: Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the effectiveness of surgery in:

a. Ulcerative
b. Crohn’s Disease

A

UC: Curative
CD: Not always curative, even if the affected area is cut out, it often reoccurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe 3 supportive therapies that are given for IBD

A

Nutritional support
Fluid/ electrolyte replacement
Blood transfusions/ oral iron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the three types of classic symptomatic treatment for IBD?

A

Aminosalicylates
Glucocorticoids
Immunosuppressants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the main aminosalicylate drug?

A

Mesalazine

AKA 5-aminosalicylic acid (5-ASA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a slightly more complex aminosalicylate?

A

Olsalazine (= 2 x 5-ASA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What type of drug are aminosalicylates?

A

Anti-inflammatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the mechanism of anti-inflammatory action of aminosalicylates.

A

Bind to PPAR receptors, acting as transcription modulators
Downregulate NFKB + MAPK, thus down regulating pro-inflammatory cytokines e.g. IL-1, TNF-alpha + IL-6
Downregulate expression of COX-2 + pro inflammatory prostaglandins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the activation of aminosalicylates.

A

Mesalazine is active, absorbed in small bowel + colon

Olsalazine must be activated by colonic flora so is active in colon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the effectiveness of aminosalicylates in Ulcerative Colitis and Crohn’s Disease.

A

Effective at inducing + maintaining remission in UC
Better than steroids at inducing remission in UC
Ineffective in inducing remission, may help maintenance but other drugs are better in CD

18
Q

Describe the use of glucocorticoids in IBD.

A

Use in UC declining because aminosalicylates are better
Glucocorticoids are still the drug of choice for inducing remission in CD
However, side effects are likely if they are used to maintain remission

19
Q

Describe some strategies for minimising the side effects of glucocorticoids.

A 
Topical administration (e.g. enemas + suppositories) 
Low dose  
Use oral or topically administered glucocorticoid with a high first pass metabolism
20
Q

What is an example of a glucocorticoid that has relatively few side effects? Why is this?

A

Budesonide

Not absorbed, stays in gut

21
Q

Describe the effectiveness of budesonide compared to other glucocorticoids.

A

Budesonide has fewer side effects than other glucocorticoids but it is less effective at inducing remission in CD

22
Q

State an immunosuppressive agent that could be used in IBD.

A

Azathioprine

23
Q

Describe the onset of action of azathioprine.

A

Slow onset: can take 3-4 months

24
Q

Describe the activation of azathioprine.

A

Azathioprine is a pro-drug

Needs to be metabolised by gut flora to 6-mercaptopurine

25
Q

Describe the mechanism of action of azathioprine.

A

6-mercaptopurine is a purine antagonist
Interferes with DNA synthesis + cell replication
Impairs:
Cell- + antibody-mediated immune responses
Lymphocyte proliferation
Mononuclear cell infiltration
Synthesis of antibodies
Enhances: T cell apoptosis

26
Q

What are the unwanted effects of azathioprine?

A

~ 10% of patients stop treatment because of side effects
Pancreatitis
Bone marrow suppression
Hepatotoxicity
Increased risk (4 fold) of lymphoma + skin cancer

27
Q

Describe the metabolism of azathioprine.

A

3 routes of metabolism of azathioprine:
Route resulting in production of beneficial active metabolites also causes myelosuppression (6-TGN)
Route resulting in hepatotoxic metabolites with no beneficial effect (6-MMP)
Xanthine Oxidase Pathway: produces inert metabolites (6-TU)

28
Q

In what clinical situation could there be a problem with azathioprine metabolism?

A

If patient is taking allopurinol
Allopurinol is used to treat gout + is a xanthine oxidase inhibitor
Results in azathioprine being shunted down the hepatotoxic + myelosuppressive routes of metabolism

29
Q

When is Azathioprine used in Crohn’s disease?

A

Not for active disease
Used for maintaining remission
Glucocorticoid sparing- can reduce glucocorticoid dose

30
Q

What are the 4 potential mechanisms of manipulating the gut microbiome?

A

Exclusive enternal nutrition (EEN): Liquid diet, allows resting of mucosa + recovery of gut flora, hard to maintain + unpalatable
Probiotic therapies: in maintenance of remission of UC
Faecal Microbiota Replacement Therapy (FMT): in UC
Antibiotics: Rifaximin
Interferes with bacterial transcription by binding to RNA polymerase
Induces + sustains remission in moderate CD
Potentially beneficial in UC

31
Q

Give an example of an anti-TNF-alpha antibody

A

Infliximab (IV)

32
Q

Describe the effectiveness of anti-TNF- antibodies in Crohn’s Disease.

A

60% of patients respond within 6 weeks

33
Q

Describe the mechanism of action of anti-TNF-alpha antibodies.

A

Anti TNF-alpha reduces activation of TNF-alpha receptors in the gut
Reduces downstream inflammatory events
Induces cytolysis of cells expressing TNF-alpha
Promotes apoptosis of activated T cells

34
Q

Describe the pharmacokinetics of anti-TNF-alpha antibodies.

A

Given intravenously
Long half-life: 9.5 days
Most patients relapse between 8-12 weeks
Repeat infusion given after 8 weeks

35
Q

What is a problem with anti-TNF-alpha therapy that may require changes in the treatment guidelines?

A

~50% of responders stopped responding after 3 years

Due to production of anti-drug antibodies + increased drug clearance

36
Q

What are the adverse effects of anti-TNF-alpha therapy?

A 
Increased risk of tuberculosis  
Risk of reactivating dormant TB  
Increased risk of septicaemia 
Worsening heart failure  
Increased risk of demyelinating disease  
Increased risk of malignancy  
Can be immunogenic
37
Q

List 3 local clinical features of IBD

A

Abdominal pain/ cramping
Diarrhoea, bloody faeces
Mouth ulcers

38
Q

List 6 systemic clinical features of IBD

A 
Anaemia
Fever
Arthritic pain
Skin rashes
Uveitis
Weight loss
39
Q

Name 2 glucocorticoids. What is the MOA of glucocorticoids in IBD?

A

Prednisolone + Budesonide
Activate intracellular glucocorticoid receptors which then act as positive or negative transcription factors
Potent anti-inflammatory + immunosuppressive actions

40
Q

List 3 strategies for minimising unwanted side effects of IBD drugs

A

Topical administration
Use low dose in combination with another drug
Use drug with high hepatic first pass metabolism so little escapes into systemic circulation

YR2 LCRS Pharm (34 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions